Crossmark

The significance of selegiline/(−)-deprenyl after 50 years in research and therapy (1965–2015)

Published Online: 2016-08-02

Published Print: 2016-11

Authors

Miklya, I
License Information

Text and Data Mining valid from 2016-08-02

Version of Record valid from 2016-08-02
More Information

Article History

Received: 2 July 2015

Revised: 30 November 2015

Accepted: 15 December 2015

First Online: 2 August 2016

Competing interests

: The author declares no conflict of interest.

Document is current